12th Annual Nantz National Alzheimer Center Symposium - EXHIBIT REGISTRATION
You are NOT confirmed to exhibit until you register.
Dear Corporate Partner,
It is our pleasure to invite you to exhibit at our Nantz Symposium hosted at the Houston Methodist Research Institute on Friday, February 17, 2023. On behalf of our Course Director, Dr. Joseph Masdeu and the Office of Continuing Medical Education (CME) we graciously extend the opportunity for you to join us as an exhibitor and/or sponsor!
We estimate that this annual conference will attract approximately 100 in-person attendees and 150 virtual attendees – all potential customers for your products and services.
I encourage you to take full advantage of this excellent opportunity to network with your target market as an exhibitor. Exhibiting companies will have the opportunity to share their educational materials and interact with participants.
Due to our limited number of exhibit openings, we hope you will take this opportunity and contact us now to register.
Please feel free to contact firstname.lastname@example.org if you have any questions or need additional information.
Joseph C. Masdeu, MD, PhD
Graham Family Distinguished Chair for Neurological Sciences, Stanley H. Appel Department of Neurology
Professor of Neurology, Academic Institute
Full Member, Research Institute
Director, Nantz National Alzheimer Center
Weill Cornell Medical College
Date and Time
Friday, February 17, 2023 | 7:30am – 4:00pm
Houston Methodist Research Institute
6670 Bertner Ave.
2nd Floor Pre-Function Space
Houston, TX 77030
EXHIBIT FEE: $1350
- One 6’ x 3’ table-top exhibit with two chairs
- Exhibiting companies may send a maximum of two (2) representatives to staff their exhibit table.
- Company logo will be located on the virtual exhibit page
- Recognition in the webpage and activity materials
NOTE: Companies may purchase one exhibit ONLY.
- Recognize the clinical signs and symptoms that define DLB
- Discuss the co-pathologies that are frequently present in DLB
- Identify the genetic correlates of DLB
- Identify the different clinical and research biomarkers and their differences
- Describe and recognize the impact of the progressive symptoms on caregivers
- Discuss the current and future landscape of clinical trials in DLB
|7:30 AM||Registration and Breakfast|
|8:30 AM||Welcome||Stanley H. Appel, MD|
|8:35 AM||Nantz Symposium Welcome||Jim Nantz, III|
|8:40 AM||Nantz Symposium Overview||Joseph C. Masdeu, MD, PhD|
|8:45 AM||Clinical Aspects of DLB and the Evolution of its Clinical Criteria||John-Paul Taylor, MD|
|9:25 AM||Q & A Discussion|
|9:35 AM||DLB Neuropathology and Coincident Co-Pathologies||Jon B. Toledo, MD, PhD|
|10:15 AM||Q & A Discussion|
|10:35 AM||Genetics of DLB||Sonja W. Scholz, MD, PhD|
|11:15 AM||Q & A Discussion|
|11:25 AM||Imaging Biomarkers in DLB||Kejal Kantarci, MD|
|12:05 AM||Q & A Discussion|
|1:30 PM||Biofluid Biomarkers in DLB||Lynn Bekris, PhD|
|2:10 PM||Q & A Discussion|
|2:15 PM||Clinical Progression in DLB and Effects on Patients and Caregivers||Melissa J. Armstrong, MD|
|2:55 PM||Q & A Discussion|
|3:15 PM||Challenges and Opportunities in DLB Clinical Trials||James B. Leverenz, MD, PhD|
|3:55 PM||Q & A Discussion|
- STEP 1 - Select the applicable fee and add to cart to complete the checkout process.
- STEP 2 - Once registered, on the week of the conference you will receive an email from Jalissa (email@example.com) for more details on exhibiting.